Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis
- Authors: Loginov V.I.1,2, Burdennyy A.M.1, Filippova E.A.1, Pronina I.V.1, Kazubskaya T.P.3, Kushlinsky D.N.3, Ermilova V.D.3, Rykov S.V.4, Khodyrev D.S.4,5, Braga E.A.1,2
-
Affiliations:
- Institute of General Pathology and Pathophysiology
- Research Center of Medical Genetics
- Blokhin Russian Cancer Research Center
- State Research Institute for Genetics and Selection of Industrial Microorganisms, Kurchatov Institute National Research Center
- Federal Research Clinical Center of Specialized Types of Medical Care and Medical Technologies, Federal Biomedical Agency of Russia
- Issue: Vol 52, No 5 (2018)
- Pages: 693-700
- Section: Molecular Cell Biology
- URL: https://journal-vniispk.ru/0026-8933/article/view/163676
- DOI: https://doi.org/10.1134/S0026893318050102
- ID: 163676
Cite item
Abstract
It is known that microRNAs (miRNAs) are able to dynamically regulate gene expression. At the same time, methylation can reduce expression of miRNA encoding genes and, therefore, reduce their inhibitory effects on mRNAs of target genes, including those of oncogenes, that promoting the development of tumors of different localization. The role of miRNA hypermethylation in the pathogenesis of ovarian cancer is not completely understood; so we conducted a search for new hypermethylated and potentially suppressor miRNA genes in ovarian tumors. Four new miRNA genes (MIR-107, MIR-130b, MIR-203a, MIR-1258) commonly hypermethylated (28‒52% ) in tumor tissues vs 4‒7% in paired histologically normal tissues, p < 0.01, were identified in a representative set of 54 ovarian cancer samples using methylation-specific PCR. It was shown that hypermethylation of MIR-130b, MIR-203a, and MIR-1258 genes is significantly (p ≤ 0.05) associated with metastasis of ovarian cancer. These results suggest the involvement of four miRNAs (miR-107, miR-130b, miR-203a, and miR-1258) and hypermethylation of their encoding genes in the pathogenesis of ovarian cancer.
Keywords
About the authors
V. I. Loginov
Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics
Author for correspondence.
Email: loginov7w@gmail.com
Russian Federation, Moscowa, 125315; Moscow, 115478
A. M. Burdennyy
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
Russian Federation, Moscowa, 125315
E. A. Filippova
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
Russian Federation, Moscowa, 125315
I. V. Pronina
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
Russian Federation, Moscowa, 125315
T. P. Kazubskaya
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 115478
D. N. Kushlinsky
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 115478
V. D. Ermilova
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 115478
S. V. Rykov
State Research Institute for Genetics and Selection of Industrial Microorganisms,Kurchatov Institute National Research Center
Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 117545
D. S. Khodyrev
State Research Institute for Genetics and Selection of Industrial Microorganisms,Kurchatov Institute National Research Center; Federal Research Clinical Center of Specialized Types of Medical Care and Medical Technologies,
Federal Biomedical Agency of Russia
Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 117545; Moscow, 115682
E. A. Braga
Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics
Author for correspondence.
Email: eleonora10_45@mail.ru
Russian Federation, Moscowa, 125315; Moscow, 115478
Supplementary files
